欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/5542/004
药品名称Paliperidon-ratiopharm 100 mg Depot-Injektionssuspension
活性成分
    • paliperidone palmitate 156.0 mg
剂型Prolonged-release suspension for injection
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Paliperidon-ratiopharm 100 mg Depot-Injektionssuspension
互认成员国 - 产品名称
    • Norway (NO)
    • France (FR)
    • Poland (PL)
      Paliperidone Teva
    • Portugal (PT)
    • Hungary (HU)
      PALIPERIDON TEVA 100 mg retard szuszpenziós injekció
    • Romania (RO)
      Paliperidonă Teva 100 mg suspensie injectabilă cu eliberare prelungită
    • Austria (AT)
    • Ireland (IE)
    • Sweden (SE)
    • Belgium (BE)
    • Iceland (IS)
    • Slovenia (SI)
    • Bulgaria (BG)
    • Spain (ES)
    • Italy (IT)
    • Slovakia (SK)
    • Croatia (HR)
    • Cyprus (CY)
      Paliperidone/Teva 100mg Prolonged-release suspension for injection
    • Lithuania (LT)
    • Estonia (EE)
    • Luxembourg (LU)
    • Greece (GR)
    • Latvia (LV)
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Netherlands (NL)
    • Finland (FI)
许可日期2019/07/17
最近更新日期2024/03/01
药物ATC编码
    • N05AX13 paliperidone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase